Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results

2 years ago

FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton…

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care

2 years ago

Following Nuvo’s NASDAQ Listing, Addition of Machado Brings Strong Health and Impact Experience to Remote Pregnancy Monitoring PioneerTEL AVIV, Israel,…

Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations

2 years ago

Company Implementing Next Phase of Its Recombinant Spider Silk Business PlanANN ARBOR, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kraig…

Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s

2 years ago

Fitness Now a Key Component of Noom's Whole-Person Health Solution For All Members NEW YORK, May 09, 2024 (GLOBE NEWSWIRE)…

ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones

2 years ago

Completed enrollment in izokibep Phase 3 trial in hidradenitis suppurativa and enrollment completion in Phase 2b/3 trial in uveitis expected…

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

2 years ago

WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring…

ORYZON to Provide Corporate Progress Updates at Several Events in May

2 years ago

Bio-Equity Europe 2024Asebio Investor Day 2024RSC Hot Topics: Covalent Drug DiscoveryForo Medcap BME 2024 MADRID, Spain and CAMBRIDGE, Mass., May…

Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension

2 years ago

- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial…

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

2 years ago

Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership…

Dental Influencers Alliance Attendees Praise Halo Dental Technologies’ Digital Mirror at Annual Get Together

2 years ago

Halo-Preview Image The Halo Digital Mirror revolutionizes dental tools, transforming patient interaction and advancing oral health services Halo Preview Image…